Proficio Capital Partners LLC Has $208,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Proficio Capital Partners LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 24.6% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 512 shares of the company’s stock after selling 167 shares during the quarter. Proficio Capital Partners LLC’s holdings in HCA Healthcare were worth $208,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Terra Nova Asset Management LLC boosted its stake in HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after purchasing an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV raised its position in HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares during the last quarter. Waldron Private Wealth LLC raised its holdings in shares of HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management grew its position in HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after purchasing an additional 30 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in shares of HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after acquiring an additional 30 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on HCA. UBS Group lifted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Oppenheimer increased their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Royal Bank of Canada increased their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a report on Wednesday, November 6th. Finally, TD Cowen cut their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $385.00.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 1.1 %

HCA opened at $358.11 on Tuesday. The business’s fifty day simple moving average is $389.61 and its 200 day simple moving average is $356.55. HCA Healthcare, Inc. has a 52 week low of $229.28 and a 52 week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock has a market cap of $90.71 billion, a PE ratio of 16.08, a P/E/G ratio of 1.36 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is currently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.